Divi's Laboratories shares climb 3%; stock crosses Rs 1 lakh crore m-cap mark
The pharma sector has been among the top beneficiaries of the COVID-19 pandemic and the stock of Divi's has been among the top performer.
Update: 2020-12-17 07:13 GMT
The pharma sector has been among the top beneficiaries of the COVID-19 pandemic and the stock of Divi's has been among the top performer.